Postpartum high blood pressure: trying enalapril after delivery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase 3 interventional trial investigates whether enalapril can be used after childbirth to better control blood pressure in women who had preeclampsia or related hypertensive disorders. Participants are postpartum adults enrolled in a remote monitoring program and will be randomized to receive enalapril versus standard postpartum treatment. The study aims to see if enalapril provides effective血 pressure control with potential cardiovascular benefits while monitoring safety. The rationale is that postpartum hypertension can progress to chronic cardiovascular risk, and ACE inhibitors may offer advantages over current regimens.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Postpartum individuals
* ≥18 years old
* Hypertensive disorder of pregnancy
* Enrolled in Women and Infants Hospital Hypertension Equity remote monitoring program.

Exclusion Criteria:

* Maternal cardiac disease
* Individuals with pre-pregnancy hypertension or diabetes
* Allergy or contraindication to enalapril

Where it's running

• Women and Infants Hospital
  Providence, Rhode Island, United States Recruiting

Study contacts

• Principal investigator: Alisse Hauspurg, MD — Women and Infants Hospital-Rhode Island
• Study coordinator: Alisse Hauspurg, MD
• Email: ahauspurg@carene.org
• Phone: 401-274-1122

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders

  This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728656

• Lowering blood pressure in pregnant women with hypertensive disorders to prolong pregnancy

  This study is testing if lowering blood pressure in pregnant women with high blood pressure can help them stay pregnant longer and improve outcomes for both mom and baby.

  Recruiting at 2 sites University of Alabama at Birmingham · Birmingham, Alabama and 1 other locations · NCT05676476

• Community health worker support to lower blood pressure after pregnancy with high blood pressure

  Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07778966

• Progesterone to Prevent Preeclampsia in Early Pregnancy

  This trial tests whether nightly vaginal progesterone started before 12 weeks can lower the chance of preeclampsia in low-risk pregnant people.

  Recruiting Phase 4 Medical University of South Carolina · Charleston, South Carolina · NCT07448597

• Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy

  This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.

  Recruiting Phase 4 Alexandra Hospital, Athens, Greece · Athens, Attica · NCT07361679

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.